Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Myeloid 3Lymphoid 3Plasma cell 2Sarcoma 1Classical hematology 1

Conditions

Anemia, Refractory, with Excess of Blasts 36Leukemia 32Myelodysplastic Syndromes 29Leukemia, Myeloid, Acute 27Leukemia, Myelomonocytic, Chronic 23Congenital Abnormalities 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Myeloproliferative Disorders 10Leukemia, Myelomonocytic, Acute 10Blast Crisis 10Leukemia, Monocytic, Acute 9Leukemia, Megakaryoblastic, Acute 9Leukemia, Erythroblastic, Acute 9Leukemia, Myeloid, Accelerated Phase 8Anemia, Refractory 8Myelodysplastic-Myeloproliferative Diseases 7Lymphoma 7Thrombocytopenia 6Leukemia, Myeloid, Chronic-Phase 6Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 5Leukemia, Lymphocytic, Chronic, B-Cell 5Primary Myelofibrosis 4Neoplasms, Plasma Cell 4Multiple Myeloma 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Hodgkin Disease 4

Interventions

Cyclophosphamide 12fludarabine phosphate 10Mycophenolic Acid 8Busulfan 8Peripheral Blood Stem Cell Transplantation 7Cyclosporine 7Tacrolimus 6Cord Blood Stem Cell Transplantation 6Antilymphocyte Serum 6Whole-Body Irradiation 5Melphalan 5Filgrastim 5Radiotherapy 4Methotrexate 4Methylprednisolone 3Etoposide 3Immunoenzyme Techniques 2Flow Cytometry 2tipifarnib 1thymoglobulin 1fludarabine 1Valganciclovir 1Transplantation 1Thiotepa 1Therapeutics 1Tetradecanoylphorbol Acetate 1Sirolimus 1Polymerase Chain Reaction 1Pentostatin 1Influenza Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pdgfra-Associated Chronic Eosinophilic Leukemia × Cytarabine × Classical hematology × Clear all
NCT00281879 2017-09-27

Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

OHSU Knight Cancer Institute

Phase 2 Terminated
200 enrolled 11 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡